Ana Barrenechea-Unceta

San Sebastian, PV, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

PSMA-PET as an emerging tool for response assessment in metastatic prostate cancer (mPC): Revolution and necessary evolution.

PSMA-PET as an emerging tool for response assessment in metastatic prostate cancer (mPC): Revolution and necessary evolution.

Journal: Revista espanola de medicina nuclear e imagen molecular

Published: December 29, 2025

PSMA-PET as an emerging tool for response assessment in metastatic prostate cancer (mPC): Revolution and necessary evolution.

PSMA-PET as an emerging tool for response assessment in metastatic prostate cancer (mPC): Revolution and necessary evolution.

Journal: Revista espanola de medicina nuclear e imagen molecular

Published: December 29, 2025

PET/CT in breast cancer.

PET/CT in breast cancer.

Journal: Revista espanola de medicina nuclear e imagen molecular

Published: February 12, 2025

Targeted sequencing of selected functional genes in patients with wild-type transthyretin amyloidosis.

Targeted sequencing of selected functional genes in patients with wild-type transthyretin amyloidosis.

Journal: BMC research notes

Published: March 19, 2023

Coexistence of Positive 99mTc-DPD Scintigraphy and Monoclonal Gammopathy: A Frequent Challenge.

Coexistence of Positive 99mTc-DPD Scintigraphy and Monoclonal Gammopathy: A Frequent Challenge.

Journal: Acta Cardiologica Sinica

Published: March 12, 2021

Cardiac Transthyretin Amyloidosis: A Nuclear Medicine Leading Role. Situation in a Spanish Center and "State of the Art" in Nuclear Medicine.

Cardiac Transthyretin Amyloidosis: A Nuclear Medicine Leading Role. Situation in a Spanish Center and "State of the Art" in Nuclear Medicine.

Journal: Clinical nuclear medicine

Published: February 25, 2021

Echocardiographic markers of cardiac amyloidosis in patients with heart failure and left ventricular hypertrophy.

Echocardiographic markers of cardiac amyloidosis in patients with heart failure and left ventricular hypertrophy.

Journal: Cardiology journal

Published: February 02, 2021

DISCOVERY: prevalence of transthyretin (TTR) mutations in a US-centric patient population suspected of having cardiac amyloidosis: a comment.

DISCOVERY: prevalence of transthyretin (TTR) mutations in a US-centric patient population suspected of having cardiac amyloidosis: a comment.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: October 12, 2020

A descriptive study of transthyretin amyloidosis in a tertiary hospital without a referral unit.

A descriptive study of transthyretin amyloidosis in a tertiary hospital without a referral unit.

Journal: Revista clinica espanola

Published: September 08, 2020

Clinical manifestations in hereditary amyloidosis with the variant Glu54Gln transthyretin: a comment.

Clinical manifestations in hereditary amyloidosis with the variant Glu54Gln transthyretin: a comment.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: January 08, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026